Refractory hypertension (RfHTN) is a phenotype of antihypertensive therapy failure described as uncontrolled BP (≥130/80 mm Hg), regardless of adequate doses of 5 or more different classes of antihypertensive medications incorporating a long-acting thiazide-like diuretic (chlorthalidone) and a mineralocorticoid receptor antagonist (MRA).
The global burden of CHD is believed to be relatively constant with 0.9 percent of children being born with CHD.
An Overview of Rosuvastatin/Ezetimibe Association for the Treatment of Hypercholesterolemia and Mixed Dyslipidemia
Elevated serum level of low-density lipoprotein cholesterol (LDL-C) is highly correlated with an enhanced risk to arise coronary artery disease and other atherosclerosis-related diseases.
Diabetes adults are at an increased risk of fracturing a bone as compared to the general adults.
Low-Density Lipoproteins Cause Atherosclerotic Cardiovascular Disease: Pathophysiological, Genetic, and Therapeutic Insights: A Consensus Statement from the European Atherosclerosis Society Consensus Panel
Non-invasive imaging in the PESA (Progression of Early Subclinical Atherosclerosis) study revealed that 71% and 43% of middle-aged men and women, respectively, have evidence of subclinical atherosclerosis.
Inflammatory Cell Infiltration in Left Atrial Appendageal Tissues of Patients with Atrial Fibrillation and Sinus Rhythm
The prime states susceptible to atrial fibrillation (AF) are aging, arterial hypertension, coronary artery disease, congestive heart failure and valvular heart disease.